Decamethonium BromideCAS# 541-22-0 |
- Naphthoquine phosphate
Catalog No.:BCC1784
CAS No.:173531-58-3
- Mefloquine hydrochloride
Catalog No.:BCC1737
CAS No.:51773-92-3
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 541-22-0 | SDF | Download SDF |
| PubChem ID | 10921 | Appearance | Powder |
| Formula | C16H38Br2N2 | M.Wt | 418.29 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | DMSO : 50 mg/mL (119.53 mM; Need ultrasonic) H2O : ≥ 50 mg/mL (119.53 mM) *"≥" means soluble, but saturation unknown. | ||
| Chemical Name | trimethyl-[10-(trimethylazaniumyl)decyl]azanium;dibromide | ||
| SMILES | C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-] | ||
| Standard InChIKey | HLXQFVXURMXRPU-UHFFFAOYSA-L | ||
| Standard InChI | InChI=1S/C16H38N2.2BrH/c1-17(2,3)15-13-11-9-7-8-10-12-14-16-18(4,5)6;;/h7-16H2,1-6H3;2*1H/q+2;;/p-2 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Decamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent.
Target: nAChR
Decamethonium (Syncurine) is a depolarizing muscle relaxant or neuromuscular blocking agent, and is used in anesthesia to induce paralysis. Decamethonium, which has a short action time, is similar to acetylcholine and acts as a partial agonist of the nicotinic acetylcholine receptor. In the motor endplate, it causes depolarization, preventing further effects to the normal release of acetylcholine from the presynaptic terminal, and therefore preventing the neural stimulus from affecting the muscle. In the process of binding, decamethonium actually activates (depolarizes) the motor endplate, but since the decamethonium itself is not degraded, the membrane remains depolarized and unresponsive to normal acetylcholine release [1]. References: | |||||
Decamethonium Bromide Dilution Calculator
Decamethonium Bromide Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.3907 mL | 11.9534 mL | 23.9069 mL | 47.8137 mL | 59.7671 mL |
| 5 mM | 0.4781 mL | 2.3907 mL | 4.7814 mL | 9.5627 mL | 11.9534 mL |
| 10 mM | 0.2391 mL | 1.1953 mL | 2.3907 mL | 4.7814 mL | 5.9767 mL |
| 50 mM | 0.0478 mL | 0.2391 mL | 0.4781 mL | 0.9563 mL | 1.1953 mL |
| 100 mM | 0.0239 mL | 0.1195 mL | 0.2391 mL | 0.4781 mL | 0.5977 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Decamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent.
- L-Carnitine inner salt
Catalog No.:BCN1229
CAS No.:541-15-1
- 2-(1-Hydroxy-1-methylethyl)-4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one
Catalog No.:BCN1422
CAS No.:54087-32-0
- Isoastilbin
Catalog No.:BCN5719
CAS No.:54081-48-0
- Palosuran
Catalog No.:BCC4311
CAS No.:540769-28-6
- Tofacitinib (CP-690550) Citrate
Catalog No.:BCC2189
CAS No.:540737-29-9
- Etonogestrel
Catalog No.:BCC5230
CAS No.:54048-10-1
- Albendazole Oxide
Catalog No.:BCC4757
CAS No.:54029-12-8
- Amifampridine
Catalog No.:BCC5185
CAS No.:54-96-6
- Pentylenetetrazole
Catalog No.:BCC7453
CAS No.:54-95-5
- Isoniazid
Catalog No.:BCC9003
CAS No.:54-85-3
- Cinanserin hydrochloride
Catalog No.:BCC6653
CAS No.:54-84-2
- Pilocarpine HCl
Catalog No.:BCC4702
CAS No.:54-71-7
- Isovaleramide
Catalog No.:BCC4668
CAS No.:541-46-8
- Muscone
Catalog No.:BCN6275
CAS No.:541-91-3
- 15-Hydroxydehydroabietic acid
Catalog No.:BCN5720
CAS No.:54113-95-0
- 9-Benzylcarbazole-3-carboxaldehyde
Catalog No.:BCC8800
CAS No.:54117-37-2
- Apoptosis Inhibitor
Catalog No.:BCC1143
CAS No.:54135-60-3
- Neoisoastilbin
Catalog No.:BCN6532
CAS No.:54141-72-9
- Flecainide acetate
Catalog No.:BCC1578
CAS No.:54143-56-5
- Vicriviroc Malate
Catalog No.:BCC1230
CAS No.:541503-81-5
- Apilimod
Catalog No.:BCC5286
CAS No.:541550-19-0
- 1-Monopalmitin
Catalog No.:BCN7749
CAS No.:542-44-9
- Cimaterol
Catalog No.:BCC6647
CAS No.:54239-37-1
- 3-Benzoylpyridine
Catalog No.:BCC8623
CAS No.:5424-19-1
Decamethonium bromide-mediated inhibition of embryonic muscle development.[Pubmed:14997390]
Anat Embryol (Berl). 2004 Apr;208(1):75-85.
This study determined the effect of Decamethonium Bromide (DMBr), a non-competitive blocker of the neuromuscular junction, on skeletal muscle development during chick embryogenesis. Decamethonium Bromide caused generalized edema and high mortality with treated embryos rarely surviving beyond day 16 of incubation. Muscle degeneration was grossly evident on the muscles of abdomen, pectoral girdle, and leg. Semi-thin sections showed a high infiltration of macrophages in treated embryos and a massive degenerative process. Electron microscopy showed that both fast and slow fibers formed in the control and treated embryos, but those of the treated embryos failed to form myofibrils. Other organ systems, such as the heart and the gut, appeared histologically normal throughout the course of treatment. To investigate possible nerve independent action of DMBr on muscle development we determined the effect of this compound on the growth and differentiation of the C2C12 skeletal muscle cell line. DMBr treatment of C2C12 cell cultures did not affect the growth or survival of the cells, even at a tenfold higher concentration than that used in ovo, but myosin heavy chain expression was dramatically inhibited. We conclude that DMBr has a nerve independent blocking inhibition effect on myosin heavy chain synthesis in the developing avian embryo besides the recognized role as a non-competitive post-synaptic blocker of the neuromuscular junction.
